Shanghai Kehua Bio-engineering Co (SZSE:002022) Margin of Safety % (DCF FCF Based) : N/A (As of Jun. 19, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Shanghai Kehua Bio-engineering Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Shanghai Kehua Bio-engineering Co's Margin of Safety % (DCF FCF Based)

For the Medical Devices subindustry, Shanghai Kehua Bio-engineering Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Kehua Bio-engineering Co's Margin of Safety % (DCF FCF Based) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Kehua Bio-engineering Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Shanghai Kehua Bio-engineering Co's Margin of Safety % (DCF FCF Based) falls into.

Shanghai Kehua Bio-engineering Co Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Margin of Safety % (DCF FCF Based)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233

Website

http://www.skhb.com

Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.

Executives

Li Ming	Executives
He Jian Wen	Executives
Ji Yu Ming	Supervisors
Li Ji	Executives
Sha Li Wu	Director
Wang Man	Directors, executives
Tang Wei Guo	Director

Shanghai Kehua Bio-engineering Co (SZSE:002022) Headlines

No Headlines